Immediate Impact
33 standout
Citing Papers
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
2024 Standout
Works of Rachel Wei being referenced
Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Rachel Wei | 166 | 39 | 41 | 138 | 124 | 17 | 259 | |
| Andrea Heider | 177 | 14 | 61 | 136 | 103 | 16 | 289 | |
| H Schefer | 137 | 76 | 54 | 155 | 85 | 14 | 323 | |
| Kevin Tay | 158 | 23 | 38 | 182 | 69 | 22 | 313 | |
| Fabrice Jardin | 80 | 20 | 58 | 109 | 61 | 21 | 271 | |
| Nataliya Kuptsova‐Clarkson | 61 | 18 | 32 | 81 | 96 | 16 | 228 | |
| W. Sanger | 120 | 37 | 28 | 136 | 73 | 12 | 226 | |
| R Hoyt | 89 | 25 | 41 | 111 | 89 | 13 | 296 | |
| Tove Wästerlid | 115 | 21 | 30 | 163 | 58 | 27 | 256 | |
| Marjan Ertault | 88 | 18 | 38 | 218 | 83 | 14 | 302 | |
| Anne Kirsti Blystad | 181 | 15 | 40 | 227 | 73 | 14 | 321 |
All Works
Loading papers...